Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Baldamus

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Early or delayed onset of cyclosporine by sequential immunosuppression?P Wienand, T Schröder, C Baldamus
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Donor conditions and graft survival--a retrospective studyP Wienand, T Schröder, D Stippel, et al.
Transplantation Proceedings|October 1, 1991
Which donor factors have an influence on recipient and graft survival? Retrospective analysis of 308 renal transplants at a single centreP Wienand, T Schröder, D Stippel, et al.
Transplantation Proceedings|October 1, 1990
Preliminary results of a prospectively randomized trial of ALG vs OKT3 for steroid-resistant rejection after renal transplantation in the early postoperative periodU J Hesse, P Wienand, C Baldamus, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
CMV prophylaxis after renal transplantation with immunoglobulin or CMV-hyperimmunoglobulin--a prospective clinical trialD Stippel, P Wienand, N Weissenberg, et al.
Klinische Wochenschrift|September 15, 1987
Graft survival and long-term renal function after sequential conventional cyclosporin A therapy in cadaver kidney transplantation--a prospective randomized trialR Grundmann, U Hesse, P Wienand, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
Cyclosporin A: early or delayed onset by prophylactic immunosuppression?P Wienand, J Isenberg, D Stippel, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
The risk of infection following OKT3 and antilymphocyte globulin treatment for renal transplant rejection: results of a single center prospectively randomized trialU J Hesse, P Wienand, C Baldamus, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Goodpasture syndrome: comparison of the disease course under initially massive immunosuppression with and without bilateral nephrectomy]W Fassbinder, M Amthor, C Baldamus, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 2, 2002
A rationale for an individualized administration frequency of epoetin beta: a pharmacological perspectiveF Locatelli, C Baldamus, G Villa, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Early or delayed onset of cyclosporine by sequential immunosuppression?P Wienand, T Schröder, C Baldamus
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Donor conditions and graft survival--a retrospective studyP Wienand, T Schröder, D Stippel, et al.
Transplantation Proceedings|October 1, 1991
Which donor factors have an influence on recipient and graft survival? Retrospective analysis of 308 renal transplants at a single centreP Wienand, T Schröder, D Stippel, et al.
Transplantation Proceedings|October 1, 1990
Preliminary results of a prospectively randomized trial of ALG vs OKT3 for steroid-resistant rejection after renal transplantation in the early postoperative periodU J Hesse, P Wienand, C Baldamus, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
CMV prophylaxis after renal transplantation with immunoglobulin or CMV-hyperimmunoglobulin--a prospective clinical trialD Stippel, P Wienand, N Weissenberg, et al.
Klinische Wochenschrift|September 15, 1987
Graft survival and long-term renal function after sequential conventional cyclosporin A therapy in cadaver kidney transplantation--a prospective randomized trialR Grundmann, U Hesse, P Wienand, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
Cyclosporin A: early or delayed onset by prophylactic immunosuppression?P Wienand, J Isenberg, D Stippel, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
The risk of infection following OKT3 and antilymphocyte globulin treatment for renal transplant rejection: results of a single center prospectively randomized trialU J Hesse, P Wienand, C Baldamus, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Goodpasture syndrome: comparison of the disease course under initially massive immunosuppression with and without bilateral nephrectomy]W Fassbinder, M Amthor, C Baldamus, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 2, 2002
A rationale for an individualized administration frequency of epoetin beta: a pharmacological perspectiveF Locatelli, C Baldamus, G Villa, et al.
Pageof 2